stockrow
Monday 9 November 2026
Export ATTO’s income statement to Excel — free account
Attovia Therapeutics, Inc.
ATTO
15.27
0.27
+1.80%
Follow ATTO
Alert me
Attovia Therapeutics, Inc. (ATTO) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AURA Aura Biosciences, Inc. compare | n/m |
| CGEM Cullinan Therapeutics, Inc. compare | n/m |
| SANA Sana Biotechnology, Inc. compare | n/m |
| SLDB Solid Biosciences Inc. compare | n/m |
| ACHV Achieve Life Sciences, Inc. compare | n/m |
| LXRX Lexicon Pharmaceuticals, Inc. compare | n/m |
| OABI OmniAb, Inc. compare | n/m |
| DNA Ginkgo Bioworks Holdings, Inc. compare | n/m |
| ATTO Attovia Therapeutics, Inc. | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)